MANDATO, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 2.500
EU - Europa 636
AS - Asia 334
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
OC - Oceania 1
Totale 3.479
Nazione #
US - Stati Uniti d'America 2.497
IT - Italia 221
CN - Cina 155
UA - Ucraina 154
IE - Irlanda 101
VN - Vietnam 76
DE - Germania 66
TR - Turchia 41
IL - Israele 40
FI - Finlandia 34
SE - Svezia 30
IN - India 17
CZ - Repubblica Ceca 10
AT - Austria 8
GB - Regno Unito 8
EU - Europa 5
FR - Francia 4
BR - Brasile 3
CA - Canada 3
KR - Corea 3
AU - Australia 1
JP - Giappone 1
LK - Sri Lanka 1
Totale 3.479
Città #
Ann Arbor 567
Woodbridge 317
Chandler 288
Princeton 222
Jacksonville 190
Wilmington 167
Houston 145
Ashburn 106
Dublin 95
Dong Ket 76
Naples 46
Beijing 41
Nanjing 41
Izmir 40
Dearborn 39
Andover 35
Boardman 35
Pellezzano 33
Salerno 27
Washington 26
Mestre 23
Düsseldorf 16
Shenyang 16
Los Angeles 14
Norwalk 13
Pune 13
Fairfield 12
West Jordan 11
Brno 10
Hebei 10
Seattle 9
Jiaxing 8
Nanchang 8
Tianjin 8
Vienna 8
San Diego 7
Arba 5
Eboli 5
Redwood City 5
Rome 5
Cambridge 4
Chennai 4
Edinburgh 4
Esslingen am Neckar 4
Lappeenranta 4
Cagliari 3
Changsha 3
Chieti 3
Geumjeong-gu 3
Munich 3
Nocera Inferiore 3
Oliveto Citra 3
Ottawa 3
Rio De Janeiro 3
Arienzo 2
Assemini 2
Catania 2
Frankfurt am Main 2
Haikou 2
Helsinki 2
Montesarchio 2
Napoli 2
Stockholm 2
Taizhou 2
Villa Castelli 2
Albano di Lucania 1
Casoria 1
Cetara 1
Chongqing 1
Cinisello Balsamo 1
Colombo 1
Costa Mesa 1
Dormagen 1
Falkenstein 1
Gunzenhausen 1
Hangzhou 1
Hounslow 1
Howell 1
Huzhou 1
Indiana 1
Istanbul 1
Jinan 1
Kunming 1
London 1
Menlo Park 1
Messina 1
Milan 1
Modena 1
Mountain View 1
Nagold 1
Nanning 1
New York 1
Orange 1
Paradise 1
Perth 1
San Antonio 1
San Jose 1
Schio 1
Shaoxing 1
Springfield 1
Totale 2.846
Nome #
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 119
Atypical celiac disease presenting as obesity-related liver dysfunction. 113
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 105
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 100
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 99
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 93
Autoimmune manifestations in pediatric liver transplantation recipients 92
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 92
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 91
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 85
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 85
A systematic review of pediatrics NAFLD therapy: year 2012 85
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 85
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 84
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 82
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 82
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 81
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 79
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 76
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 75
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 74
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 74
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 74
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 72
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 71
More on vitamin E therapy 70
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 60
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 59
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 59
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 55
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 52
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 50
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 44
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 43
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 41
Nutrition and Liver Disease 37
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 34
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 31
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 29
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 26
Global multi-stakeholder endorsement of the MAFLD definition 26
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 25
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 25
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 24
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 24
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 24
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 24
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 24
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 23
The gut-liver axis as a target of liver disease management 22
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 22
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 21
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 20
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 18
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 18
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 16
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 16
Humanization interventions in general pediatric wards: a systematic review 15
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 15
Genetics, epigenetics and transgenerational transmission of obesity in children 14
Drug dosing in children with obesity: a narrative updated review 13
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 11
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 11
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 10
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 10
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 9
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 9
Italian children seem to be spared from the mysterious severe acute hepatitis outbreak: A report by SIGENP Acute Hepatitis Group 8
Editorial: The broader aspects of non-alcoholic fatty liver disease in children 7
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 6
Is the perfect screening of paediatric non-alcoholic fatty liver disease still an unmet target? 6
Letter to the editor: The burgeoning field of progressive familial intrahepatic cholestasis 4
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 3
Insights on Transition of Care-Related Deaths of Young Adults Who Were Recipients of Pediatric Liver Transplantation 3
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 3
Cytochrome 209: A new hepatic target of immune reactions after orthotopic liver transplantation 3
Risk factors for neural tube defects:: analysis of common genetic variants of methylenetetrahydrofolate reductase and cystathionine β-synthase 3
Identification of CYP2C19 as a new hepatic target of autoantibodies developing after orthotopic liver transplantation 3
Bronchiolitis: Compliance with guidelines 3
The challenging diagnosis of hepatosplenic cat scratch disease in children 3
Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity‐related Liver Disease 2
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 2
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 2
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 2
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 2
More on Vitamin E Therapy [2] (multiple letters) 2
Nutritional therapy in liver transplantation 2
Serum alanine aminotransferase: Are we still far from a one‐size‐fits‐all pediatric reference cutoff strategy? 2
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 2
Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency 1
The debate on paracetamol hepatotoxicity continues 1
Letter to the Editor: More on Non-Alcohol/Non-Metabolic Dysfunction-Associated Steatohepatitis 1
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 1
Pediatric Acute Liver Failure 1
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 1
Totale 3.640
Categoria #
all - tutte 11.299
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.299

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 42 2
2019/2020418 95 3 40 14 36 51 41 10 30 28 65 5
2020/2021336 4 30 32 1 35 9 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024395 29 48 43 25 32 89 41 24 14 43 7 0
Totale 3.640